This information was published on 2026-03-28T12:02:56 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2639509 |
| (220) |
26 Mar 2026
|
| (300) |
US, 02 Oct 2025, 99425465
|
| (511) (510) |
Class 5
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions |
| (540) |
|
| (550) | Figurative |
| (730) |
ImmunoGen, Inc.
|
| (750) |
Minter Ellison
|
Find out more about publications on the About page.